Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy

Hypertension in Pregnancy

Volumn 33, Issue 4, 2014, Pages 375-388

  Yamaleyeva, Liliya M ^a   Merrill, David C ^a,b   Ebert, Thomas J ^c   Smith, Thomas L ^a   Mertz, Heather L ^a   Brosnihan, K Bridget ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b AURORA HEALTH CARE   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin (1 7); Noninvasive methods; Pregnancy; Regional (skin and brachial) blood flow

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN I; ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; IMPEDANCE; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; PREECLAMPSIA; PREGNANT WOMAN; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; THIRD TRIMESTER PREGNANCY; VASCULAR DISEASE; VASCULAR RESISTANCE; VEIN OCCLUSION PLETHYSMOGRAPHY; BLOOD FLOW; CASE CONTROL STUDY; FOREARM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; VASCULARIZATION; YOUNG ADULT;

ADULT; ANGIOTENSIN I; CARDIAC OUTPUT; CASE-CONTROL STUDIES; FEMALE; FOREARM; HUMANS; MICROCIRCULATION; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 84911487961     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2014.911884     Document Type: Article

References (38)

1. Merrill DC, Karoly M, Chen K, et al. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002;18:239-45.
2. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9.
3. Benjamin N, Rymer J, Todd SD, et al. Sensitivity to angiotensin II of forearm resistance vessels in pregnancy. Br J Clin Pharmacol 1991;32:523-5.
4. Gant NF, Whalley PJ, Everett RB, et al. Control of vascular reactivity in pregnancy. Am J Kid Dis 1987;IX:303-7.
5. Santos RAS, Brosnihan KB, Jacobsen DW, et al. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension (Suppl II) 1992;19:II-56-61.
6. Valdes G, Neves LA, Anton L, et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 2006;27:200-7.
7. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. ajp heart and circulatory 2005;289:H1560-6.
8. Santos RA, Ferreira AJ, Simoes e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008;93:519-27.
9. Neves LAA, Williams AF, Averill DB, et al. Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology 2003;14:3338-43.
10. Sampaio WO, Nascimento AAS, Santos RA. Regulation of cardiovascular signaling by Kinins and products of similar converting enzyme systems. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am J Physiol Heart Circ Physiol 2003;284:H1985-94.
11. Belardinelli L, Shryock J, West A, et al. Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation 1984;70:1083-91.
12. Burchell SA, Yu M, Takiguchi SA, et al. Evaluation of a continuous cardiac output and mixed venous oxygen saturation catheter in critically ill surgical patients. Crit Care Med 1997;25:388-91.
13. Sasaki S, Higashi Y, Nakagawa K, et al. Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension. Hypertension 2001;38:90-4.
14. Ueda S, Masumori-Maemoto S, Wada A, et al. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. J Hypertens 2001;19:2001-9.
15. Petrie JR, Ueda S, Morris AD, et al. How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol 1998;45:131-9.
16. Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008;18:109-16.
17. Ekenvall L, Lindblad LE, Norbeck O, Etzell BM. Alpha-adrenoceptors and cold-induced vasoconstriction in human finger skin. Am J Physiol 1988;255:H1000-3.
18. Eneroth-Grimfors E, Lindblad LE, Westgren M, et al. Iontophoresis of vasoactive drugs. Effect on peripheral blood flow during pregnancy. Acta Obstet Gynecol Scand 1991;70:25-8.
19. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883-91.
20. Sampaio WO, Souza dos Santos RA, Faria-Silva R, et al. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007;49:185-92.
21. Schindler C, Bramlage P, Kirch W, Ferrario CM. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag 2007;3:125-37.
22. Ferrario CM. Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology. Current Hypertens Reports 2003;5:129-34.
23. Gironacci MM, Adamo HP, Corradi G, et al. Angiotensin (1-7) induces MAS receptor internalization. Hypertension 2011;58:176-81.
24. de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.
25. Wilsdorf T, Gainer JV, Murphey LJ, et al. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension 2001;37:1136-40.
26. Ueda S, Masumpori-Maemoto S, Ashino K, et al. Angiotensin-(1-7) attenuates vasoconstriction evoked by Angiotensin II but not by noradrenaline in man. Hypertension 2000;35:998-1001.
27. Weissgerber TL, Davies GAL, Tschakovsky ME. Brachial artery flow-mediated dilation is not affected by pregnancy or regular exercise participation. Clin Sci 2011;121:355-65.
28. Savvidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. The Lancet 2003;361:1511-17.
29. Campia U, Choucair WK, Bryant MB, et al. Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol 2002;40:754-60.
30. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013;209:544.e1-12.
31. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol 1998;92:174-8.
32. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
33. Suboc TM, Dharmashankar K, Wang J, et al. Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiol Rep 2013;1:1-10.
34. Tur E, Tamir A, Guy RH. Cutaneous blood flow in gestational hypertension and normal pregnancy. J Invest Dermatol 1992;99:310-14.
35. Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123-8.
36. Cankar K, Potocnik N, Strucl M. Alteration of skin laser-Doppler flux response to local cooling in gestational hypertension. Clin Auton Res 2010;20:183-90.
37. Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 2000;36:400-4.
38. Takase B, Goto T, Hamabe A, et al. Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of pre-eclampsia. J Hum Hypertens 2003;17:697-704.